Two peptides were annotated with dipeptidyl peptidase-IV (DPP-IV)-inhibitory activity, with one from alpha-lactalbumin showing an IC50 of 13.8 μM, indicating potential for glucose metabolism regulation and Type 2 diabetes management. Here, DPP4 is linked to type 2 diabetes mellitus.